Association between Toll-Like Receptor 4 Gene and inflammatory bowel disease among Jordanian patients

Pharmacy Practice

  • Malek Zihlif1Department of Pharmacology, School of Medicine, The University of Jordan, Amman, Jordan.
  • Zainab Zakaraya2Biopharmaceutics and Clinical Pharmacy Department, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
  • Rawan Nael3Department of Laboratory Medical Sciences, Faculty of Allied Health Sciences, The Hashemite University, Zarqa, Jordan; School of Medicine, The University of Jordan, Amman, Jordan.
  • Abed Al-Rahman Al-Shudiefat3Department of Laboratory Medical Sciences, Faculty of Allied Health Sciences, The Hashemite University, Zarqa, Jordan; School of Medicine, The University of Jordan, Amman, Jordan.
  • Mohammad Alshhab1Department of Pharmacology, School of Medicine, The University of Jordan, Amman, Jordan.
  • Ahmad Sundookah4Department of Clinical Nutrition and Dietetics, Applied Science Private University, Amman 11931, Jordan.
  • Ahmad R. Alsayed5Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman 11937, Jordan.

Volume 22 Issue 4 Pages 1-7

DOI: 10.18549/PharmPract.2024.4.3047

Abstract

Background: Inflammatory bowel disease (IBD) is a set of chronic inflammatory gastrointestinal disorders that affects many patients worldwide, with a peak incidence in early adult life. The Toll-like receptor 4 (TLR4) binds Lipopolysaccharide (LPS) with the assistance of accessory proteins and activates signal transduction pathways of the innate immune system. TLR4 is significantly up-regulated in the active disease phase of IBD. It has been reported that the two most common single nucleotide polymorphisms (SNPs) of TLR4 (Asp299Gly and Thr399Ile) have been shown to suspend TLR4-mediated LPS signaling in vitro and are associated with endotoxin hyporesponsiveness in human beings. This study aims to determine if there is an association between certain TLR4 (Asp299Gly and Thr399Ile) polymorphisms and IBD in Jordanian patients, to determine the genotype and allele frequencies of TLR4 (Asp299Gly and Thr399Ile) polymorphisms among IBD and healthy Jordanian groups, to determine the association between the age and IBD Jordanian patients. Methods: 96 IBD patients aged between 17-72 years and 96 healthy subjects without genetic kinship related to the disease were enrolled and genotyped by TLR4 (Asp299Gly and Thr399Ile) polymorphisms using the polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) assay methods. Results: There was no significant association between TLR4 (Asp299Gly and Thr399Ile) polymorphisms and IBD compared with healthy subjects among Jordanian subjects. Conclusions: IBD incidence was significantly higher in younger age compared to older age, which could be due to the higher activity of the digestive system in those patients compared to older adults.

Keywords

  • IBD
  • TLR4
  • genotype
  • polymorphism
  • jordan
Pharmacy Practice

Loading…